Cefepime Associated With Higher Mortality Risk Than Other Beta-Lactam Antibiotics
Source Summary
A systematic review and meta-analysis of 110 randomized trials involving over 22,000 patients found that cefepime was linked to higher odds of all-cause mortality compared with other beta-lactam antibiotics. The analysis examined mortality outcomes across multiple clinical trials of the antibiotic.
Why it matters
This finding may influence clinical prescribing decisions for cefepime, a commonly used antibiotic, by highlighting a potential safety concern regarding patient mortality outcomes.
